This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hamad Bin Khalifa University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Khalid Hussain: Innovator in Stem Cell Research
Introduction
Khalid Hussain is a prominent inventor based in Doha, Qatar. He has made significant contributions to the field of stem cell research, particularly in the generation of induced pluripotent stem cells (iPSCs). His work focuses on understanding genetic mutations and their implications for various disorders.
Latest Patents
Khalid Hussain holds a patent titled "Generation of induced pluripotent stem cells (IPSCs) with GLUT2 mutation or FOXA2 deletion, methods of preparing same, and methods of using same." This patent describes a method for generating human induced pluripotent stem cells from patients with specific genetic mutations. The methods outlined in the patent aim to create human cell models for conditions such as diabetes, Fanconi Bickel Syndrome, and other related disorders. The patient-specific iPSC cell lines developed through this research can be utilized for mechanistic studies, drug screening, and understanding the roles of GLUT2 and FOXA2 in human cell types.
Career Highlights
Khalid Hussain is affiliated with Khalifa University, where he continues to advance his research in stem cell technology. His innovative approaches have garnered attention in the scientific community, contributing to the understanding of genetic disorders and potential therapeutic avenues.
Collaborations
Khalid has collaborated with notable colleagues, including Essam M Abdelalim and Ahmed K Elsayed. These partnerships enhance the research efforts and broaden the impact of their findings in the field of stem cell research.
Conclusion
Khalid Hussain's work in generating induced pluripotent stem cells represents a significant advancement in medical research. His contributions are paving the way for new insights into genetic disorders and potential treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile